RISING TO THE CHALLENGE ANNUAL REPORT 04–05 CONTENTS 1

First Page		Document Content
Date: 2009-02-03 07:59:10 Emerging technologies The Ottawa Hospital Cell biology Gene therapy Stem cell Duchenne muscular dystrophy John Cameron Bell Biology Biotechnology Ottawa Hospital Research Institute		RISING TO THE CHALLENGE ANNUAL REPORT 04–05 CONTENTS 1 Add to Reading List Source URL: www.ohri.ca Download Document from Source Website File Size: 328,22 KB Share Document on Facebook

	Biotechnology, BS "DBEFNJD.BQ 5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT DocID: 1xTqy - View Document
	PDF Document DocID: 1wroO - View Document
	Building A Better Mousetrap: Patenting Biotechnology In The European Community DocID: 1vr7C - View Document
	BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod DocID: 1vq6b - View Document
	Biotechnology Consultation Agency Response Letter BNF DocID: 1vpUZ - View Document